Bloodroot
Sanguinaria
Sanguinaria, commonly known as bloodroot, originates from North America and has a long history of traditional use. While its specific applications are not well-documented in traditional medicine, studies suggest potential benefits such as improved acute kidney injury through reduced inflammation and oxidative stress, and antimicrobial properties against Staphylococcus aureus by affecting membrane integrity and IGPD activity. Scientific evidence indicates that sanguinarine, a key constituent of Sanguinaria, may also exhibit anticancer properties by modulating signaling pathways in vitro. However, the strength of these findings is currently limited due to the preliminary nature of the research. No significant safety concerns or drug interactions have been reported for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study identifies several phytoconstituents from eleven traditional medicinal plants, including Sanguinaria canadensis, that exhibit potential anticancer properties by modulating key signaling pathways in vitro.
- Sanguinarine improved cisplatin-induced acute kidney injury in mice by reducing inflammation, oxidative stress, and cellular damage.
- Sanguinarine demonstrated antimicrobial properties and interference with biofilm formation in Staphylococcus aureus by affecting membrane integrity and IGPD activity.
- The study found that sanguinarine's intestinal absorption is significantly affected by P-gp proteins and involves multiple transport mechanisms.
Frequently asked questions
What is Bloodroot?
Bloodroot (Sanguinaria) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Bloodroot?
4 sourced findings are recorded for Bloodroot; the strongest carries evidence grade D. For example: The study identifies several phytoconstituents from eleven traditional medicinal plants, including Sanguinaria canadensis, that exhibit potential anticancer properties by modulating key signaling pathways in vitro.
How strong is the evidence for Bloodroot?
The strongest finding for Bloodroot carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Bloodroot safe? What are the side effects?
No major safety issues are recorded for Bloodroot in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Bloodroot interact with medications?
No drug interactions are recorded for Bloodroot in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Bloodroot?
Bloodroot is also known as: Сангвинария.
Is Bloodroot a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Studies on pharmacokinetic properties and intestinal absorption mechanism of sanguinarine chloride: in vivo and in situ. literature abstract metadata
- T2 Targeting membrane integrity and imidazoleglycerol-phosphate dehydratase: Sanguinarine multifaceted approach against Staphylococcus aureus biofilms. literature abstract metadata
- T2 Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal Cancer Signaling Pathways. literature abstract metadata
- T2 Attenuation of cisplatin-induced acute kidney injury by sanguinarine: modulation of oxidative stress, inflammation, and cellular damage. literature abstract metadata